Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Principe actif")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 9751

  • Page / 391
Export

Selection :

  • and

Methods of following drug release from controlled release dosage formsGOULD, P. L.British polymer journal. 1983, Vol 15, Num 4, pp 172-176, issn 0007-1641Article

LA DISPONIBILITE BIOLOGIQUE DES MEDICAMENTSHIRTZ J.1976; ACTUAL. PHARMACOL.; FR.; DA. 1976; VOL. 28; PP. 77-106; BIBL. 29 REF.Article

A quality evaluation strategy for multi-sourced active pharmaceutical ingredient (API) starting materialsGAVIN, Peter F; OLSEN, Bernard A; WIRTH, David D et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 4, pp 1251-1259, issn 0731-7085, 9 p.Article

Physical approaches for the delivery of active ingredients in foodsUBBINK, Job; KRÜGER, Jessica.Trends in food science & technology (Regular ed.). 2006, Vol 17, Num 5, pp 244-254, issn 0924-2244, 11 p.Conference Paper

Natural plant chemicals: sources of industrial and medicinal materialsBALANDRIN, M. F; KLOCKE, J. A; WURTELE, E. S et al.Science (Washington, D.C.). 1985, Vol 228, Num 4704, pp 1154-1160, issn 0036-8075Article

Pharmaceutical applications of functionalized polymersPETRAK, K.Reactive polymers. 1989, Vol 10, Num 2-3, pp 231-237, issn 0923-1137, 7 p.Conference Paper

CHARACTERISTICS OF POTASSIUM RELEASE FROM ORAL COMMERCIAL TABLETS IN VITRO AND ITS APPARENT AVAILABILITY = CARACTERISTIQUES DE LA LIBERATION DE POTASSIUM A PARTIR DES COMPRIMES DU COMMERCE IN VITRO ET LEUR DISPONIBILITE APPARENTEKRISTOFFERSSON E; KAUKINEN A; KRISTISTOFFERSSON R et al.1974; FARM. AIKAKAUSLEHTI; SUOMI; DA. 1974; VOL. 83; NO 2; PP. 51-58; BIBL. 11REF.Article

BEITRAEGE ZUR LIBERATION VON ARZNEISTOFFEN AUS SUSPENSIONSSALBEN. VII. IN VITRO-FREISETZUNG VON PREDNISOLON AUS VERSCHIEDENARTIGEN SALBENGRUNDLAGEN. = LIBERATION DE SUBSTANCES ACTIVES A PARTIR DE POMMADES. VII. LIBERATION IN VITRO DE PREDNISOLONE A PARTIR DE DIVERS EXCIPIENTS POUR POMMADESHORSCH W; KOEGEL J; NITZSCHE R et al.1975; PHARMAZIE; DTSCH.; DA. 1975; VOL. 30; NO 11; PP. 724-728; BIBL. 56 REF.Article

DETERMINATION IN VITRO DES PARAMETRES INFLUENCANT LA DIFFUSION DE L'HYDROCORTISONE A PARTIR DE PREPARATIONS DERMOPHARMACEUTIQUESGILLET VANDERBRUGGEN M; ROLAND M.1975; J. PHARM. BELG.; BELG.; DA. 1975; VOL. 30; NO 1; PP. 3-22; ABS. ANGL. NEERL. ALLEM.; BIBL. 4REF.Article

RELEASE OF A DRUG FROM HOMOGENEOUS OINTMENTS CONTAINING THE DRUG IN SOLUTION.SPANG BRUNNER BH; SPEISER PP.1976; J. PHARM. PHARMACOL.; G.B.; DA. 1976; VOL. 28; NO 1; PP. 23-28; BIBL. 3 REF.Article

THE PROBLEM OF GENERICS.FROMMING KH.1976; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; GERM.; DA. 1976; VOL. 14; NO 4; PP. 242-244Article

VERFUEGBARKEITSPRUEFUNG IN VITRO-ERFORDERNIS, MOEGLICHKEITEN, GRENZEN = RECHERCHE DE LA BIODISPONIBILITE IN VITRO. EXIGENCES, POSSIBILITES, LIMITESDIBBERN HW.1973; PHARM. INDUSTR.; DTSCH.; DA. 1973; VOL. 35; NO 2; PP. 76-78; ABS. ANGL.; BIBL. 50 REF.Serial Issue

LA LIBERATION DES SUBSTANCES MEDICAMENTEUSES A PARTIR DES COMPRIMES. II. LA LIBERATION DE LA MERCAPTO-PURINE A PARTIR DE DIFFERENTES MASSES POUR COMPRIMESNERLO H; CZARNECKI W.1975; ACTA POLON. PHARM.; POLOGNE; DA. 1975; VOL. 32; NO 3; PP. 365-370; ABS. RUSSE ANGL.; BIBL. 9 REF.Article

BIOAVAILABILITY FROM PHARMACEUTICAL DOSAGE FORMSSTENLAKE JB.1974; ANALYST; G.B.; DA. 1974; VOL. 99; NO 1185; PP. 824-837; BIBL. 1P.1/2Article

BIOLOGIC AVAILABILITY, DETERMINANT FACTOR OF THERAPEUTIC ACTIVITY OF DRUGS. STATEMENT OF THE PROBLEM AND PHYSIOLOGICAL CONSIDERATIONS = BIODISPONIBILITE, FACTEUR DETERMINANT DE L'ACTIVITE THERAPEUTIQUE DES MEDICAMENTS. ETAT DU PROBLEME ET CONSIDERATIONS PHYSIOLOGIQUESWAGNER JG.1973; DRUG INTELLIG. CLIN. PHARM.; U.S.A.; DA. 1973; VOL. 7; NO 4; PP. 168-176; BIBL. 14REF.Serial Issue

Marketing issues in bulk active ingredients. Contact manufacturingBOZZOLI, V.Chimica oggi. 1992, Vol 10, Num 1-2, pp 67-68, issn 0392-839XArticle

Factorial design of experiment for stability studies in the development of a tablet formulationEL-BANNA, H. M; ISMAIL, A. A; GADALLA, M. A. F et al.Pharmazie. 1984, Vol 39, Num 3, pp 163-165, issn 0031-7144Article

The targeting of drugs using polymeric microspheresDAVIS, S. S; ILLUM, L.British polymer journal. 1983, Vol 15, Num 4, pp 160-164, issn 0007-1641Article

Analisis cualitativo y cuantitativo del sulfato de 8-hidroxiquinoleina monohidrato = Analyse qualitative et quantitative du sulfate de 8-hydroxyquinoléine monohydrate = Qualitative and quantitative analysis of sulfate of 8-hydroxyquinoline monohydratedMINGOT LORENZO, M; RUPEREZ CUENCA, M. M.1983, Num 13, 11 p.Serial Issue

» Physical Active Ingredients« for Wrinkle ReductionBÄNZIGER, S; OBERMAYER, B.SÖFW-Journal. 2012, Vol 138, Num 4, issn 0942-7694, 24-32 [6 p.]Article

Active pharmaceutical ingredientsSTOKER, Andy.Chemical engineer (London). 2002, Num 732, pp 38-39, issn 0302-0797Article

Drug glycosides: potential prodrugs for colon-specific drug deliveryFRIEND, D. R; CHANG, G. W.Journal of medicinal chemistry (Print). 1985, Vol 28, Num 1, pp 51-57, issn 0022-2623Article

Flavonoïdes de glycoxylon huberi Ducke = Flavonoids from Glycoxylon huberi DuckeJACQUEMIN, H; BOISSONNAT, A; FAUGERAS, G et al.Annales pharmaceutiques françaises. 1985, Vol 43, Num 5, pp 521-525, issn 0003-4509Article

Sur la résine d'Epema grandiflora (Aublet) Benth. (Légumineuses césalpiniacées) = Resin of Eperna grandiflora (Aublet) Benth. (Caesalpiniaceae)GOURNELIS, D; VIDAL-TESSIER, A. M; DELAVEAU, P et al.Annales pharmaceutiques françaises. 1985, Vol 43, Num 6, pp 565-572, issn 0003-4509Article

Zur Liberation von wasserlöslichen Wirkstoffen aus Polymereinbettungen. II: Die Bedeutung der durch technologische Verfahren bedingten Makrostruktur der Einbettungsarzneiformen für die Wirkstoffliberation = La libération des substances solubles dans l'eau à partir d'inclusions dans des polymères II. L'importance de la macrostructure des formes médicamenteuses incluses déterminée par le procédé technologique sur la libération du principe actif = On the liberation of water-soluble active agents from polymer embeddings Part 2: The importance of the manufacturing-process dependent macrostructure of the embedded dosage form in active agent liberationSÜSS, W.Pharmazie. 1983, Vol 38, Num 9, pp 601-607, issn 0031-7144Article

  • Page / 391